Tag: Bacteria

Posted on

Cool Images: Bewitching Bacteria

by
2 comments

Some bacteria benefit us as part of our microbiome—the vast collection of microorganisms that live in and on our bodies—while others can make us sick. Whether helpful or dangerous, bacteria can appear colorful and striking under a microscope. These photos provide just a small peek into the incredible diversity of these microbes.

A green pattern resembling a flower on a red background. Credit: Liyang Xiong and Lev Tsimring, BioCircuits Institute, UCSD.

This floral pattern emerged when a researcher grew two strains of bacteria—Acinetobacter baylyi (red) and Escherichia coli (green)—together for 2 days in a petri dish. A. baylyi are found in soil and typically don’t pose a threat to humans, although some strains can cause infections. E. coli normally live in the intestines of people and animals. Most strains are harmless, but some can cause food poisoning or other illnesses.

Continue reading “Cool Images: Bewitching Bacteria”
Posted on

Pathways: The Superbug Issue

by
1 comment
Cover of Pathways student magazine showing blueish-green virus particles and text that reads, Stop the Spread of Superbugs (Yes, you can help!). Cover of Pathways student magazine.

NIGMS and Scholastic bring you our latest issue of Pathways, which focuses on superbugs—infectious microbes that can’t be fought off with medicines. Viruses that can’t be prevented with vaccines, such as the common cold, and antibiotic-resistant bacteria both fall into this category.

Pathways, designed for students in grades 6 through 12, is a collection of free resources that teaches students about basic science and its importance to health, as well as exciting research careers.

Continue reading “Pathways: The Superbug Issue”
Posted on

Shedding Light on Sepsis

by
1 comment

Sepsis is the body’s overactive and extreme response to an infection. It’s unpredictable, can progress rapidly, and affects more than 1.7 million people in the United States each year. Without prompt treatment, it can lead to tissue damage, organ failure, and death. NIGMS supports state-of-the-art sepsis research, including the development of rapid diagnostics and new therapeutics. September is Sepsis Awareness Month, and we’re highlighting a few resources that offer more information about this condition.

Our infographic provides details at a glance on basic statistics and the future of sepsis research. It’s also available in Spanish.

Continue reading “Shedding Light on Sepsis”
Posted on

Exploring Nature’s Treasure Trove of Helpful Compounds

by
0 comments
An oblong shell with white-and-brown markings. A cone snail shell. Credit: Kerry Matz, University of Utah.

Over the years, scientists have discovered many compounds in nature that have led to the development of medications. For instance, the molecular structure for aspirin came from willow tree bark, and penicillin was found in a type of mold. And uses of natural products aren’t limited to medicine cabinet staples and antibiotics. A cancer drug was originally found in the bark of the Pacific yew tree, and a medication for chronic pain relief was first isolated from cone snail venom. Today, NIGMS supports scientists in the earliest stages of investigating natural products made by plants, fungi, bacteria, and animals. The results could inform future research and bring advances to the field of medicine.

Continue reading “Exploring Nature’s Treasure Trove of Helpful Compounds”
Posted on

Sepsis: Using Big Data to Cut a Killer Down to Size

by and
0 comments
A geographical outline of the U.S. with the text More than 1.7 million people get sepsis each year in the United States. View the full infographic for more facts about sepsis.

Sepsis is a serious medical condition caused by an overwhelming response to infection that damages tissues and organs. It’s unpredictable, progresses quickly, can strike anyone, and is a leading cause of hospital-related deaths. In the U.S. alone, nearly 270,000 people die each year from sepsis. Those who survive sepsis often end up in the hospital again, and some have long-term health complications. Early treatment is key for many patients to survive sepsis, yet doctors can’t easily diagnose it because it’s so complex and each patient is different.

Despite decades of research, sepsis remains a poorly understood condition with limited diagnostic tools and treatment. To tackle these obstacles, scientists Vincent Liu, Christopher Seymour, and Hallie Prescott have started using a “big data” approach, which relies on complex computer programs to sift through huge amounts of information. In this case, the computers analyze data such as demographic information, vital signs, and routine blood tests in the electronic health records of sepsis patients. The goal is to find patterns in the data that might help doctors understand, predict, and treat sepsis more effectively.

Continue reading “Sepsis: Using Big Data to Cut a Killer Down to Size”
Posted on

The Meat of the Matter: Learning How Gut Microbiota Might Reduce Harm from Red Meat

by
0 comments
Drawing of intestines with a magnifying glass showing bacteria within the intestine.Microbiota in the intestines. Credit: iStock.

Research on how diet impacts the gut microbiota has rapidly expanded in the last several years. Studies show that diets rich in red meat are linked to diseases such as colon cancer and heart disease. In both mice and humans, researchers have recently discovered differences in the gut microbiota of those who eat diets rich in red meat compared with those who don’t. This is likely because of a sugar molecule in the red meat, called N-glycolylneuraminic acid (Neu5Gc), that our bodies can’t break down. Researchers believe the human immune system sees Neu5Gc as foreign. This triggers the immune system, causing inflammation in the body, and possibly leads to disease over time.

Continue reading “The Meat of the Matter: Learning How Gut Microbiota Might Reduce Harm from Red Meat”
Posted on

RNA Polymerase: A Target for New Antibiotic Drugs?

by and
1 comment

DNA, with its double-helix shape, is the stuff of genes. But genes themselves are only “recipes” for protein molecules, which are molecules that do the real heavy lifting (or do much of the work) inside cells.

RNAP illustrated as a crab claw, clamping on a DNA double helix. Artist interpretation of RNAP grasping and unwinding a DNA double helix. Credit: Wei Lin and Richard H. Ebright.

Here’s how it works. A molecular machine called RNA polymerase (RNAP) travels along DNA to find a place where a gene begins. RNAP uses a crab-claw-like structure to grasp and unwind the DNA double helix at that spot. RNAP then copies (“transcribes”) the gene into messenger RNA (mRNA), a molecule similar to DNA.

The mRNA molecule travels to one of the cell’s many protein-making factories (ribosomes), which use the mRNA message as instructions for making a specific protein.

Continue reading “RNA Polymerase: A Target for New Antibiotic Drugs?”
Posted on

PREP Scholar’s Passion for Understanding Body’s Defenses

by
1 comment
Photo of Charmaine Nganje, with curly red shoulder-length hair and eyeglasses, smiling..

Charmaine N. Nganje, PREP scholar at Tufts University in Boston.
Credit: Katherine Suarez.

Charmaine N. Nganje

Hometown: Montgomery Village, Maryland

Influential book : The Harry Potter series (not exactly influential, but they’re my favorite)

Favorite movie/TV show: The Pursuit of Happyness/The Flash

Languages: English (and a bit of Patois)

Unusual fact: I’m the biggest Philadelphia Eagles fan from Maryland that you’ll ever meet

Hobbies: Off-peak traveling

Q. Which NIGMS program are you involved with?

A. The Postbaccalaureate Research Education Program (PREP) Link to external web site at the Sackler School of Graduate Biomedical Sciences at Tufts University in Boston.

Continue reading “PREP Scholar’s Passion for Understanding Body’s Defenses”
Posted on

Interview With a Scientist—Elhanan Borenstein: Metagenomics Systems Biology

by
0 comments


Cataloging the human microbiome—the complete collection of bacteria, fungi, archaea, protists, and viruses that live in and on our bodies—is an enormous task. Most estimates put the number of organisms who call us home on par with the number of our own cells. Imagine trying to figure out how the billions of critters influence each other and, ultimately, impact our health. Elhanan Borenstein,Link to external web site a computer scientist-cum-genomicist at the University of Washington, and his team are not only tackling this difficult challenge, they are also trying to obtain a systems-level understanding of the collective effect of all of the genes, proteins, and metabolites produced by the numerous species within the microbiome.

Continue reading “Interview With a Scientist—Elhanan Borenstein: Metagenomics Systems Biology”

Posted on

Interview With a Scientist: Andrew Goodman, Separating Causation and Correlation in the Microbiome

by
0 comments

You’ve likely heard some variation of the statistic that there are at least as many microbial cells in our body as human cells. You may have also heard that the microscopic bugs that live in our guts, on our skins, and every crevice they can find, collectively referred to as the human microbiome, are implicated in human health. But do these bacteria, fungi, archaea, protists, and viruses cause disease, or are the specific populations of microbes inside us a result of our state of health? That’s the question that drives the research in the lab of Andrew Goodman Link to external web site, associate professor of microbial pathogenesis at Yale University.

Continue reading “Interview With a Scientist: Andrew Goodman, Separating Causation and Correlation in the Microbiome”